These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37373623)

  • 1. Comparative Performance of Four Staging Classifications to Select «High-Risk» Head and Neck Cutaneous Squamous Cell Carcinomas.
    Elaldi R; Chamorey E; Schiappa R; Sudaka A; Anjuère F; Villarmé A; Culié D; Bozec A; Montaudié H; Poissonnet G
    J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.
    Ruiz ES; Karia PS; Besaw R; Schmults CD
    JAMA Dermatol; 2019 Jul; 155(7):819-825. PubMed ID: 30969315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Tumor Classifications for Cutaneous Squamous Cell Carcinoma of the Head and Neck in the 7th vs 8th Edition of the AJCC Cancer Staging Manual.
    Karia PS; Morgan FC; Califano JA; Schmults CD
    JAMA Dermatol; 2018 Feb; 154(2):175-181. PubMed ID: 29261835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.
    Inda JJ; Kabat BF; Larson MC; Slager SL; Baum CL
    J Am Acad Dermatol; 2019 Mar; 80(3):639-645. PubMed ID: 30165169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of the 8th edition American Joint Commission Cancer (AJCC) nodal staging system for patients with cutaneous squamous cell carcinoma of the head and neck.
    Liu J; Ebrahimi A; Low TH; Gao K; Palme CE; Sydney C; Ashford BG; Iyer NG; Clark JR; Gupta R
    J Surg Oncol; 2018 Mar; 117(4):765-772. PubMed ID: 29049841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma.
    Karia PS; Jambusaria-Pahlajani A; Harrington DP; Murphy GF; Qureshi AA; Schmults CD
    J Clin Oncol; 2014 Feb; 32(4):327-34. PubMed ID: 24366933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and Women's Hospital and Tübingen alternative staging systems for high-risk cutaneous squamous cell carcinoma.
    Puebla-Tornero L; Corchete-Sánchez LA; Conde-Ferreirós A; García-Sancha N; Corchado-Cobos R; Román-Curto C; Cañueto J
    J Am Acad Dermatol; 2021 Apr; 84(4):938-945. PubMed ID: 33333151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death.
    Morgan FC; Ruiz ES; Karia PS; Besaw RJ; Neel VA; Schmults CD
    J Am Acad Dermatol; 2021 Sep; 85(3):582-587. PubMed ID: 33497751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of the 8th edition American Joint Commission Cancer nodal staging system for patients with head and neck cutaneous squamous cell carcinoma: A multi-institutional study.
    Luk PP; Ebrahimi A; Veness MJ; McDowell L; Magarey M; Gao K; Palme CE; Clark JR; Gupta R
    Head Neck; 2021 Feb; 43(2):558-567. PubMed ID: 33118253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data.
    Venables ZC; Tokez S; Hollestein LM; Mooyaart AL; van den Bos RR; Rous B; Leigh IM; Nijsten T; Wakkee M
    Br J Dermatol; 2022 May; 186(5):835-842. PubMed ID: 34862598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical analysis of the 8th edition TNM staging for head and neck cutaneous squamous cell carcinoma with lymph node metastases and comparison to N1S3 stage and ITEM risk score: A multicenter study.
    Ebrahimi A; Luk PP; Low H; McDowell L; Magarey MJR; Smith PN; Perriman DM; Veness M; Gupta R; Clark JR
    J Surg Oncol; 2021 Jun; 123(7):1531-1539. PubMed ID: 33721339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Staging Systems for Non-Head and Neck Cutaneous Squamous Cell Carcinoma.
    Guerra R; Shahwan KT; Nikahd M; Hyer M; Carr DR
    Dermatol Surg; 2024 Feb; 50(2):121-124. PubMed ID: 37962141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems.
    Blechman AB; Carucci JA; Stevenson ML
    Dermatol Surg; 2019 Sep; 45(9):1117-1124. PubMed ID: 30640779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.
    Cañueto J; Burguillo J; Moyano-Bueno D; Viñolas-Cuadros A; Conde-Ferreirós A; Corchete-Sánchez LA; Pérez-Losada J; Román-Curto C
    J Am Acad Dermatol; 2019 Jan; 80(1):106-113.e2. PubMed ID: 30003984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the eighth edition of the TNM and Brigham Women's Hospital staging systems for cutaneous squamous cell carcinoma of the head and neck: a six-year review.
    Bowe CM; Houlton S; Walsh S
    Br J Oral Maxillofac Surg; 2020 Nov; 58(9):1158-1163. PubMed ID: 33071049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck.
    Sood A; Wykes J; Roshan D; Wang LY; McGuinness J; Fowler A; Ebrahimi A
    Head Neck; 2019 Jun; 41(6):1591-1596. PubMed ID: 30659690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients.
    Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
    Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck.
    Amit M; Liu C; Netto Gleber FO; Kini S; Tam S; Benov A; Aashiq M; El-Naggar AK; Moreno AC; Rosenthal DI; Glisson BS; Ferrarotto R; Wong MK; Migden MR; Li G; Khanna A; Goepfert RP; Nagarajan P; Weber RS; Myers JN; Gross ND
    Eur J Cancer; 2021 Feb; 144():169-177. PubMed ID: 33352413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the American Joint Committee on Cancer Staging in Squamous Cell Carcinoma of the Vermilion Lip.
    Yung AE; Que MS; Lo S; Aggarwal S; Hong AM; Tin MM; Clark JR; Gupta R; Ch'ng S
    Ann Surg Oncol; 2021 Jun; 28(6):3092-3099. PubMed ID: 33389299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of prognostic prediction ability of the novel Japanese risk factor scoring system in a Japanese cohort of resectable cutaneous squamous cell carcinoma: A retrospective cross-sectional study.
    Doi R; Baba N; Kato H; Nakamura M; Matsushita S; Aoki M; Fujimoto N; Kato T; Iino S; Saito S; Yasuda M; Asai J; Ishikawa M; Yatsushiro H; Kawahara Y; Inafuku K; Matsuya T; Araki R; Teramoto Y; Hasegawa M; Nakama T; Nakamura Y
    Exp Dermatol; 2023 Oct; 32(10):1682-1693. PubMed ID: 37395158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.